Beckerman will represent Elixinolâs position in hemp industryâs dynamic U.S. regulatory and advocacy environment
DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly
owned subsidiary of Elixinol Global (EXL) (ASX: EXL; OTC: ELLXF),
announces Joy Beckermanâs appointment to Elixinolâs team starting
January 1, 2019.
In Beckermanâs role as Regulatory Officer and Industry Liaison, she will advise Elixinolâs executive team on the industryâs changes and ensure Elixinolâs practices continue to meet or exceed the requirements of hempâs dynamic regulatory framework following the 2018 Farm Bill which federally legalized hemp. In addition, Beckerman will represent Elixinol in national and regional cannabis and hemp industry alliances and memberships, including the Hemp Industries Association, the National Hemp Association, Vote Hemp, and sharing Elixinolâs representation with Gabriel Ettenson at the U.S. Hemp Roundtable.
âWeâre proud to announce Joy is joining Elixinol. Joyâs contributions to the U.S. hemp industry, and her decades of advocacy, policy, and regulatory insight, are significant for their longevity, knowledge, and passion,â said Gabriel Ettenson, President, Elixinol.
âWe know Joy will be a valuable team member as Elixinol continues to lead the industry with the highest of standards,â he continued.
Beckermanâs extensive industry influence and experience has redefined hemp industry standards and advocacy and will ensure that Elixinol remains an industry leader and leads the hemp industryâs development in best practices and regulatory adherence.
In addition to serving as President of the Hemp Industries Association, a non-profit trade association founded in 1994 that represents over 1,200 hemp farmers and business members in the U.S., Beckerman is also Vice President of the U.S. Hemp Authority, which created the first certification seal program for hemp industry Current Good Manufacturing Practices and Good Agricultural Practices. She also serves as National Board Member for NORML (National Organization for the Reform of Marijuana Laws). Most recently, Beckerman has served multiple clients as Principal of Hemp Ace International, a New York-based consulting, legal support, and expert witness firm serving the global hemp community. Beckermanâs extensive background in compliance and complex civil litigation support includes high profile corporate cases and multiple multi-million-dollar civil lawsuits.
As a hemp industry leader and internationally renowned educator and public speaker, Beckerman has received accolades from industry organizations for her contributions, including earning her the 2014 âNational Hemp Activist of the Yearâ award from the Hemp Industries Association.
âI appreciate Elixinolâs âDo Good, Be Good,â philosophy which is actively demonstrated through their seed-to-sale quality standards and widely acknowledged support for the important work undertaken by non-profits,â said Beckerman.
âElixinol has already been a leading voice on regulatory, legal, and manufacturing standards and I look forward to the continued advancement of U.S. hemp and Elixinolâs advocacy and industry leadership,â she continued.
Beckerman will report to Elixinol President Gabriel Ettenson. She will remain on the Boards of leading industry institutions and continue to speak around the globe on hempâs future and the U.S. regulatory environment.
About Elixinol:
Colorado-based Elixinol, co-founded by Paul
Benhaim, hemp entrepreneur since 1991, is widely regarded as one of
the most influential CBD brands in the world. With a proven track
record of growing and extracting premium-quality hemp, Elixinol is
one of the few CBD hemp extract brands with complete seed-to-sale
control over its products. Elixinol also conducts rigorous
third-party laboratory testing and quality control. Elixinol
distributes hemp-derived CBD products in 40 countries globally
including North and South America, throughout Europe, Asia, and the
Pacific Region under its own label as well as bulk CBD and
wholesale CBD. Elixinolâs parent company EXL (elixinolglobal.com) is publicly traded on the
Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX:
ELLXF). More information available at Elixinol.com.
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]